Individual investor for 30 years, now Full-Time. MD degree. Trade daily. Long stocks only, and call options, mainly LEAPs, which I consider to be long term investments. I am a patient investor. My core is biopharma, with a few biotechs: Together, these comprise about 75% of my portfolio, and include some large core biopharmas, as well as aggressive emerging biopharmas, which I call my "Baby Bios." Of these, DEPO has sprouted wings. Others have been active of late. There is also eclectic diversification, with some retail, clothing, tech, software.. I trade daily, and look for newly listed options. [Please note that there is no check box for "Healthcare" in the "Your Interests" section].
I am an investor that is interested in much more research then your typical investor. I like to look at the numbers, but also step back and look at the big picture. I feel my strategies have been successful in identifying sound investments, and lucrative opportunities and I welcome new ideas, alternative views, and critical opinions. Criticism will usually strengthen my opinion on an potential investment, and if it actually holds validity, well, then I gain by learning something new, so its a win-win.
It's difficult to buy low and sell high, because when a stock is low, well, everyone around you is telling you that it just isn't a good investment. And when a stock is doing well, well, everyone is rating it a buy. The difficulty is being the one buying, when the crowds are yelling sell, and vice versa. It's funny how the main investment mantra, is the most difficult one to follow. Another good way to evaluate if its time to sell a stock, and take your profits, if you ask yourself would you buy more shares. And if the answer is no, well then its time to sell.
As a chemist and part-time investor, I focus on technology and natural-resource related businesses and macroeconomic events that influence their prices. I use past trends and technological developments to make decisions on companies that I would invest in. My point of view as a chemist occasionally allows a deeper look at some of the fundamentals of some companies that base their technology on chemical principles.
I retired in 1994 from a career in Pharmaceutical R&D, where I reached an executive level. My PhD is in Biochemistry. I'm a recovering risk-taker, having repeatedly lost money in the market by speculating without adequate knowledge and experience. I have made money in real estate, but the great crash left me holding some commercial property that will not sell. Currently, I am back in the market, but now a much-chastened dividend-growth stock investor, looking for income.
Work Smart AND Work Hard - No Nonsense - work everyday philosophy.Rest is for people who want 2nd place.
Losing my parents, I learned not to take anything for granted. Life will present you with major opportunities and it up to all of us to take action with those opportunities.
Being driven - has become a way of life. My parents live thru my drive and will. When your faced with challenges, one either quits or looks within and finds that will and drive to win.
Help others along the way doing one's best. I wish all of you success.
Overcoming many obstacles - I have become a better person.
2x Employee of the Year and even more hungry
Good is one thing - Great is another level
Retail Investor, Shareholder Advocate and Editor of Stocks DD blog. You are cautioned to read the disclaimer in Seeking Alpha before reading my articles. I am NOT a registered investment adviser. My articles are ONLY for informative purposes and should NOT be treated as investment advice.
My investment philosophy:
1. Invest in Strong businesses (high barriers to entry) 2. Invest in Management with excellent track record for shareholder value creation 3. Invest at undervalued prices
Invest in special situations (bankruptcy or other restructuring) or Drug development firms, where there is with an asymmetric reward/risk...where I have strong conviction on a reward event.
I am also interested in the shareholders topics in publicly listed companies:
1. Shareholder rights 2. Giving shareholders a voice incl shareholder participation in value creation 3. Improving board and management's accountability to shareholders
Be a shareholder advocate and work towards insuring boards and management "do the right thing for shareholders", maximizing and protecting shareholder's value.
More on my ideas can be found here:
Below my portfolio:
BioPharma Large: AMGN, GILD, CELG, BIIB, REGN, ALXN, BMRN, JAZZ
Biotechnology Product: SGEN, MACK, OASM, XXII, ACAD, OMER, SUPN
Biotechnology Clinical: CUR, ARRY, NWBO, CLVS, NVIV, AGEN, NK, ADRO, SRNE, ADXS, RDUS, ALNY, RVNC, AGIO, CNAT, OCRX, CEMP, MGNX, PTLA, GNFT(€), ESPR, FGEN, LJPC, AFMD, CLLS, ADAP, RGLS, CLDX, EPZM, ITCI, IMDZ, RXDX, CNCE, BLCM, KPTI, JUNO, NERV, TCON
Special Pharma/Generic: HZNP,
Gene Editing: NTLA, EDIT, CRSP, DMTX, ADVM
Consumer Services: UNP, CVS, CAH, TGT, ABC
Consumer Goods: PM, RAI, BTI, MO, FLO, VFC, Nestle(€), BUD,
Energy: COP, BP, RDS-A, RDS-B, TOT, PSX, VLO, OXY, HP
Financial: WFC, TD, BNS, TROW
Healthcare: JNJ, ABBV, GSK, ABT, NVO, BMY, NVS, AGN, RHHBY, MDT, EW, Bayer(€)
Industrial: CMI, UTX, HON,
REITs: WPC, OHI, HCN, VTR, NHI, PSA, EXR, LSI, SKT, SPG, ESS, FRT, CCP, NSA, CONE, QTS, NNN, DLR, COR, CCI, STOR
Technology: IBM, SSYS, DDD, SWKS
Utilities: DUK,SO, ED, SPKE
MLP: EPD, MMP, PAA, SEP, OKS, KMI, BPL
In Israel currency I hold: PSTI, RDHL
In Euro (€) currency I hold: Nestle, Bayer, Genfit
Acquired companies from portfolio: DYAX-->SHPG(cash); BXLT-->SHPG; RLYP-->Galencia (cash); MDVN-->PFE(cash);
Performance: without non US currency companies, dividend and acquired companies:
Portfolio A: DGI Dividend, Portfolio B Biotech, Overall, S&P500, IBB, XBI, Current Yield follow SigFig and Wikinvest is: 2.9% (Correct to 10/2016)
2016 YTD (10/1/2016): 9.66%, 5.10%, 7.88%, 6.1%, -14.32%, -5.45%
October 2016 was my worst month since I start to invest my portfolio lost 20%, but I don't sure all data right, because I taking profit from many companies and move money to beaten stocks and my portfolio monitor programs unable to show the difference.
From Israel, born in 1977, working as IT Network&Security Specialist. Chess candidate master - chess helps me to remember and follow lots of stocks and companies' business. Chess helps me to be patient and to not be afraid to take risks, to learn from my mistakes and to be resistant to losing value, same in investing. If after buying my stocks they go down it gives me an opportunity to buy more, that is how I see it. No one can predict the market and only a few investors can avoid loss of their specific stocks, diversity is a key. I was pulled in to the market by a colleague in 2014 and don’t have any regret about it, because I start to see how here in IL simple not rich man can continue his life after 40-45 if he loses his job in a high-tech company and how it is possible to buy a home here, maybe even switch this to a primary job in future. I found the “seekingalpha” website after researching the healthcare industry. First steps were ETF's, but after learning & reading a lot about fundamental and value investing and after discovering DGI philosophy, DGI bloggers switching from my ETF's into stocks. I wish to know in which businesses I hold stocks and what I am investing in. I want to invest in what I believe in. Interested in biotechnology especially in cancer treatment companies and in biotechnology in general especially unmet treatment and innovation in medicine. Early in life I wanted to be a doctor and I am interested in the medical sciences in general. Also interested in 3D printing, solar energy, robotic and innovation technology that improves our civilization and our lives. Learning about DGI here, I am proud to be a DGI Investor (learning and I continue to learn a lot from all the people I follow, sorry the list is too long to give individual BIG THANKS to everyone for their great job, hope they will continue to do that!), but some of the people I must say THANKS to, for their works, articles, research and teaching young investors and people making their first steps, people whose all articles are a MUST READ (DoctoRx - for bio/healthcare, Chuck Carnevale - for FastGraph, Value Invest, Industrial and more, David Van Knapp - for DGI, Chowder - for DGI, Bret Jensen - for Economic/Healthcare, Brad Tomas for Reit, Kanak Kanti De - for bio/healthcare, BuyandHold, Puche for their comments, and many more. Thanks for your works and for your comments!)
But in other side I think elegant and perfect portfolio need be improved DGI: Income and Growth portfolio - something like (70/30 or 70/20/10) - 70% - DGI/Income Giant/Large companies 30% - Small/Micro cap that in potential can give to Investor >500-1000% (tenbagger - Peter Lynch) or 20%- Large high growth established without dividend, 10% - small/micro with huge potential one day they can growth to be Giant/Large next (Apple,Gilead) I know my English is weak, but I am working hard to improve it. Thanks for reading my profile and giving any comments and advice.
Expert Consultant in biotechnology, intellectual property, patents, molecular genetics, genomics, gene regulation, RNA silencing, RNA interference, epigenetics
Editor in Chief, Frontiers in Plant Genetics and Genomics
Professor Emeritus at University of Arizona, School of Plant Sciences, College of Agricultural and Life Sciences, Tucson, Arizona
Private investor focused on value and GARP. Began investing in mutual funds just a month or so before Black Monday in 1987! I survived that and stayed the course. Been investing now in individual stocks for 16 years. I find that capital markets are a continual learning opportunity, particularly when one is getting his or her ass kicked! SA is a tremendous vehicle for exchanging ideas in a thoughtful and respectful manner.
Celan Bryant started her career working for two top-tier investment banks before migrating to the corporate finance arena. After completing a fellowship at Harvard University, she began a career in financial writing with a focus on reporting and sustainable business models. Ms. Bryant has an MBA with a concentration in finance and over 15 years of experience in the financial industry. For custom research reports contact firstname.lastname@example.org. Disclaimer: Any material provided is intended as general information only, and should not be considered or relied upon as a formal investment recommendation.
We are a tax consulting and company formation firm located offshore in the sunny, tax free Bahamas since 1990. I've formed over 1,030 Bahamian IBCs and 360 Anguilla IBCs since 1990.
◾Anguilla is a UK overseas territory with same tax status as Cayman Islands.
◾All the money and technology to create their offshore registration services came out of London.
◾Anguilla was one of the very first tax havens that adopted an online registry service.
◾QEII is the head of State.
◾Got questions? email email@example.com
The Caribbean tax havens have grown to rival New York and London as a place to hold family assets, and the US FET is one reason why there are so many offshore companies there.
480,000 IBCs in BVI;
100,000 “exempt companies” in Cayman;
45,000 IBCs in the Bahamas;
30,000 cos in Bermuda
25,000 IBCs in Anguilla
None of the Caribbean (tax) havens levy an estate tax.
Nobody is much interested in tax avoidance any more, so I'm posting Tom's Fishing Gallary pictures instead http://bahamasbahamas.com/images/gallery.html
Personal info here https://www.linkedin.com/profile/preview?locale=en_US&trk=prof-0-sb-preview-primary-button
and PFIC / FATCA info for planners https://www.linkedin.com/pulse/new-irs-form-8938-created-fatca-2010-can-filing-avoided-tax-havens?trk=prof-post
JPMorgan/Chase writes on U.S. Estate taxation: "Because stock of a foreign corporation (in a no tax haven) is not subject to U.S. estate tax, holding U.S. situs assets through a foreign corporation constitutes a planning opportunity." http://www.jpmfinancialservices.com/images/PDFs/EstateTaxation.pdf
I began investing in 1987. My first four investments were Budweiser, American Barrick (ABX), MCI Communication and General Dynamics. Not bad for a newbie. I'm a buy and homework type of guy. In the Jim Cramer vein. My key area's of interest are Tech, Biotech, Energy, Financials and commodities. I run my own money, eat my own cooking & I don't take prisoners'.